SCHEMBL2802709

SCHEMBL2802709

Fc1ccccc1C1Cc2cnc(NC3CCCCC3)nc2-c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.50
FGFR2 P21802 2/20 0.50
CSF1R P07333 1/20 0.50
FGFR3 P22607 1/20 0.50
ADORA1 P30542 1/20 0.44
MAPK8 P45983 2/20 0.43
MAPK9 P45984 2/20 0.43
MAPK10 P53779 2/20 0.43
MAPK14 Q16539 2/20 0.43
AXL P30530 1/20 0.41
FLT3 P36888 1/20 0.41
TYRO3 Q06418 1/20 0.41
MERTK Q12866 1/20 0.41
GAS6 Q14393 1/20 0.41
MAPT P10636 1/20 0.40
CDK2 P24941 6/20 0.39
CDK9 P50750 5/20 0.39
CDK7 P50613 4/20 0.39
CCNT1 O60563 4/20 0.39
CCNK O75909 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2804221 0.97 FGFR1 (0.51) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2804944 0.87 FGFR1 (0.50) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2803454 0.87 FGFR1 (0.50) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2806011 0.87 ADORA1 (0.49) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2806784 0.87 FGFR1 (0.60) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2805457 0.87 FGFR1 (0.60) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2806389 0.84 FGFR1 (0.49) FGFR1FGFR2CSF1RFGFR3MAPK8
SCHEMBL2802427 0.84 FGFR1 (0.51) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2804983 0.83 ADORA1 (0.47) FGFR1FGFR2CSF1RFGFR3ADORA1
SCHEMBL2804861 0.83 FGFR1 (0.61) FGFR1FGFR2CSF1RFGFR3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.